Compulsory License Archives

Free Masterclass on IP; Nokia and Daimler settle SEP patent dispute; EU submits alternative proposal to WTO against IP waiver and more

In this week’s patent news - Want to know how to file a patent? or expedite the patent process? Join us this week; Nokia and Daimer settle SEP patent dispute, sign patent licensing agreement; EU submits alternative proposal to WTO against IP waiver; and USPTO announces change to its implementation of structured text filing. Want to know how to file a patent? or expedite the patent process? Join us this week BananaIP in association with Nasscom will be…

June 7, 2021 BananaIP Reporter Intellectual Property, Patents 0Comment 1422Views 0Like

ShareFacebook

The featured image is a quote by John F. Kennedy which reads "There are risks and costs to action. But they are far less than the risks of comfortable inaction"

In Support of Prof. Arul Scaria on Compulsory Licensing for COVID Vaccines, Medicines, Diagnostics and other Technologies

During the last two days, two interesting articles addressing accessibility of medical products and methods were published. While one article in 'The Hindu' spoke about capitalism and its inherent hurdles to access, another article written by Professor Arul Scaria in 'The Wire' argued against Niti Aayog's approach towards access to COVID vaccines and medicines. In his article, Professor Scaria specifically pointed out that Government's reluctance to use the compulsory licensing mechanism as a part of the COVID vaccine/medicine access scheme…

May 30, 2021 Dr. Kalyan C. Kankanala Intellectual Property, Patents 0Comment 1485Views 0Like

ShareFacebook

Natco withdraws compulsory license, signs agreement with Eli Lilly for Barcitinib; Patent Office notifies extension of timelines and more

In this week’s patent news: Patent Office notifies Supreme Court’s order on Extensions of Timelines; Patent office announces JPO/IPR Training Course FY 2021; BananaIP and NASSCOM to organize a Master Class on IP; Panacea Biotec accuses Sanofi of patent infringement, files suit; Natco and Eli Lilly sign patent license agreement for production of Barcitinib; NATCO and Eli Lilly sign patent license agreement for production of Barcitinib; India and South Africa propose three-year patent waiver. Patent Office notifies Supreme Court’s…

May 24, 2021 BananaIP Reporter Intellectual Property, Patents 0Comment 1212Views 0Like

ShareFacebook

Natco files compulsory license request; USA approves temporary patent waiver; Ericsson and Samsung settle dispute and more

In this week’s patent news: Natco files compulsory license request for Baricitinib; USA approves temporary patent waiver; EU critical of US proposal for patent waiver, calls for removal of export restrictions; Ericsson and Samsung settle latest patent dispute, sign global patent license agreement; WIPO publishes guide on “International Registration of Industrial Designs under the Hague Agreement” and USPTO hiring hundreds of new patent examiners.  Natco files compulsory license request for Baricitinib Hyderabad based generic drug manufacturer Natco…

May 10, 2021 BananaIP Reporter Industrial Designs, Intellectual Property, Patents 0Comment 1017Views 0Like

ShareFacebook

Delhi High Court asks government to consider issuing compulsory licenses, World IP day 2021, a solemn affair this year, India – South Africa patent waiver proposal opposed again and more

In this week’s patent news and updates - World IP day 2021, a solemn affair this year; Calls for compulsory license on COVID vaccine grows stronger; Government should not hesitate in invoking compulsory licensing provisions says Delhi High Court; Intel wins patent trial involving VLSI Technology; India - South Africa patent waiver proposal opposed by EU, UK and Switzerland at WTOP TRIPS meet; Lawmakers and nonprofit groups urge Biden administration to back 'moral' patent waiver. Indian Patent Updates …

April 26, 2021 BananaIP Reporter Intellectual Property, Patents 0Comment 938Views 0Like

ShareFacebook

CPI(M) asks Government to issue compulsory license for Remdesivir, EPO creates search strategies to help fight against COVID-19 and more patent news

In this week’s Patent News – CPI(M) asks Government to issue compulsory license for manufacturing generic versions of drug – Remdesivir; EPO creates search strategies to aid scientists distinguish documents relevant to fight the COVID-19 pandemic; EUIPO and EPO to jointly host online conference on Additive Manufacturing INDIA PATENT NEWS UPDATE CPI(M) asks Government to issue compulsory license for manufacturing generic versions of drug - Remdesivir The Communist Party of India (Marxist) has reportedly requested the Central…

July 13, 2020 BananaIP Reporter Intellectual Property, Patents 0Comment 730Views 0Like

ShareFacebook

Compulsory Licensing in India – Talk by Gaurav Mishra

Mr. Gaurav Mishra, Managing Associate at BananaIP Counsels delivered a talk on the Compulsory licensing provisions in India under the Patents Act on the 3rd of June 2020 at an event organized by the Department of Science and technology, Rajasthan. The webinar event was attended by over a 100 participants including, students, lawyers, medical professionals and academicians. The talk was delivered as part of the Rajasthan, DST's laudable initiative of creating IP awareness as well as helping the attendees grasp…

June 3, 2020 BananaIP Reporter Intellectual Property, Patents 0Comment 1191Views 0Like

ShareFacebook

Statement of Working to Compulsory Licensing – Are We Missing Something?

This post was first published on 8th April, 2011. As pointed out by Supriya in her post, a compulsory license may be granted if a patent is not worked in India and reasonable efforts are made to acquire a license. Does the working of a patent in India mean that the patented invention must be manufactured in India? Reading of sections 83 and 84 of the Patents Act take us to that logical conclusion. The sections clearly point out that working…

July 25, 2019 BananaIP Reporter Intellectual Property, Patents 0Comment 677Views 0Like

ShareFacebook

Compulsory License for “Not working”

This post was first posted on 8th April, 2011. In a recent development, non-compliance with regard to the requirement of local working of patent, required under patent law, may lead to issue of compulsory licenses to generics for seven top selling drugs. The RTI query sought by SpicyIP (Way to go Spicy IP!) seeking information regarding Form 27 filings by Innovators for the top selling drugs Tarceva (Roche and OSI Pharms), Stutent (Pfizer), Nexavar (Bayer), Sprycel; Dasatinib (BMS), Pegasys (Roche), Viraferonpeg…

July 8, 2019 BananaIP Reporter Intellectual Property, Patents 0Comment 1005Views 0Like

ShareFacebook

The featured image shows the words thats all folks. this post is about the decision of two indian generic drug manufactures to drop their request for Compulsory licenses. to read more click here.

Lee and BDR decision – the End of Compulsory Licenses?!

Earlier this week, the words, “Compulsory License”, “Section 84” and “Indian pharma” once again made the headlines. This time however, it wasn’t a new case being brought forth; instead it was the decision to bury two old ones. The news reports suggested that two Indian drugmakers had given up a battle to copy drugs developed by Bristol Myers Squibb and AstraZeneca, blaming a lack of government support for cheap generics and pressure from Big Pharma. The two Indian drug makers…

April 16, 2016 BananaIP Reporter Intellectual Property, Patents 0Comment 1163Views 0Like

ShareFacebook

Celebrating 20 Years of IP Excellence

Free Masterclass on IP; Nokia and Daimler settle SEP patent dispute; EU submits alternative proposal to WTO against IP waiver and more

In Support of Prof. Arul Scaria on Compulsory Licensing for COVID Vaccines, Medicines, Diagnostics and other Technologies

Natco withdraws compulsory license, signs agreement with Eli Lilly for Barcitinib; Patent Office notifies extension of timelines and more

Natco files compulsory license request; USA approves temporary patent waiver; Ericsson and Samsung settle dispute and more

Delhi High Court asks government to consider issuing compulsory licenses, World IP day 2021, a solemn affair this year, India – South Africa patent waiver proposal opposed again and more

CPI(M) asks Government to issue compulsory license for Remdesivir, EPO creates search strategies to help fight against COVID-19 and more patent news

Compulsory Licensing in India – Talk by Gaurav Mishra

Statement of Working to Compulsory Licensing – Are We Missing Something?

Compulsory License for “Not working”

Lee and BDR decision – the End of Compulsory Licenses?!

Connect with Us

BananaIP has been acknowledged as a women-owned enterprise, certified by WEConnect International.

Connect with us